3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid
95%
- Product Code: 44336
CAS:
104373-85-5
| Molecular Weight: | 235.2823 g./mol | Molecular Formula: | C₁₂H₁₇N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01702072 | |
| Melting Point: | Boiling Point: | 418 °C at 760 mmHg | |
| Density: | 1.22g/cm3 | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring both a pyridine and piperazine moiety, makes it a versatile building block for designing drugs targeting the central nervous system. It is often employed in the development of compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, its carboxylic acid group allows for further functionalization, enabling the creation of derivatives with enhanced bioavailability or targeted activity. Researchers also explore its use in the design of ligands for receptor studies, particularly in the context of neurotransmitter systems, to better understand and modulate neurological pathways.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | Ft53,331.83 |
+
-
|
3-(4-(Pyridin-2-yl)piperazin-1-yl)propanoic acid
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring both a pyridine and piperazine moiety, makes it a versatile building block for designing drugs targeting the central nervous system. It is often employed in the development of compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, its carboxylic acid group allows for further functionalization, enabling the creation of derivatives with enhanced bioavailability or targeted activity. Researchers also explore its use in the design of ligands for receptor studies, particularly in the context of neurotransmitter systems, to better understand and modulate neurological pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :